Higher numbers of T-bet + intratumoral lymphoid cells correlate with better survival in gastric cancer

Lu-jun Chen,Xiao Zheng,Yue-ping Shen,Yi-bei Zhu,Qing Li,Junjun Chen,Rui Xia,Shu-ming Zhou,Chang-ping Wu,Xue-guang Zhang,Bin-feng Lu,Jing-ting Jiang
DOI: https://doi.org/10.1007/s00262-012-1358-6
2012-01-01
Abstract:In the present study, we studied the expression of T-bet, a key marker for type 1 immune responses, within the tumor microenvironment of gastric cancer, and analyzed its association with clinicopathological parameters. One hundred and fifty-two archival paraffin-embedded gastric tumor tissues were collected, and the expression of T-bet in these cancer tissue specimens was examined by immunohistochemistry. T-bet + tumor-infiltrating lymphocytes (TILs) in some gastric cancer tissues were further characterized by flow cytometric analysis. The density of T-bet + TILs in gastric cancer tissues in relation to patient’s clinicopathological parameters and postoperative prognosis has been analyzed. Herein, we have found significant increases in T-bet + lymphocytes in tumor tissues as compared with normal stomach tissues, gastritis tissues or gastric polyp specimens. T-bet + cells mainly consisted of CD4 + , CD8 + and CD56 + TILs. In addition, lower numbers of T-bet + TILs were associated with poor clinicopathological parameters such as invasion to muscular layer, larger tumor size and advanced cancer stages. Moreover, patients with higher numbers of T-bet + TILs have longer disease-free survival and overall survival. Thus, our study supports the idea that tumor growth elicits spontaneous type 1 cellular immune responses and tumor progression is associated with suppression of antitumor immunity. T-bet expression within tumor can serve as a prognostic indicator for gastric cancer and a potential biomarker for immunotherapy.
What problem does this paper attempt to address?